Phase 2 Readout
MPLT: Phase 2 Readout: ml-007c-ma
July 27, 2026 · ml-007c-ma. BioSniper AI can trace the company-impact path without requiring you to write the research question.
- Event date
- July 27, 2026
- Company
- MapLight Therapeutics, Inc. (MPLT)
- Drug
- ml-007c-ma
BioSniper AIPage evidence connected
Prepared research question
What could this event change, and which evidence should be watched next?
Run cited research
Traceable citations · Unknowns marked
Phase 2 Readout
Phase 2 Readout: ml-007c-ma
- Drug
- ml-007c-ma
- Indication
- schizophrenia